Form 8-K - Current report:
SEC Accession No. 0001193125-25-141756
Filing Date
2025-06-17
Accepted
2025-06-17 07:35:45
Documents
51
Period of Report
2025-06-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d18728d8k.htm   iXBRL 8-K 55873
2 EX-99.1 d18728dex991.htm EX-99.1 41433
3 EX-99.2 d18728dex992.htm EX-99.2 44683
7 GRAPHIC g18728dsp07.jpg GRAPHIC 4129
8 GRAPHIC g18728ex99_2p10g1.jpg GRAPHIC 183069
9 GRAPHIC g18728ex99_2p11g1.jpg GRAPHIC 286846
10 GRAPHIC g18728ex99_2p12g1.jpg GRAPHIC 168563
11 GRAPHIC g18728ex99_2p13g1.jpg GRAPHIC 223772
12 GRAPHIC g18728ex99_2p14g1.jpg GRAPHIC 230407
13 GRAPHIC g18728ex99_2p15g1.jpg GRAPHIC 197637
14 GRAPHIC g18728ex99_2p16g1.jpg GRAPHIC 213904
15 GRAPHIC g18728ex99_2p17g1.jpg GRAPHIC 195371
16 GRAPHIC g18728ex99_2p18g1.jpg GRAPHIC 182186
17 GRAPHIC g18728ex99_2p19g1.jpg GRAPHIC 205451
18 GRAPHIC g18728ex99_2p1g1.jpg GRAPHIC 368284
19 GRAPHIC g18728ex99_2p20g1.jpg GRAPHIC 220942
20 GRAPHIC g18728ex99_2p21g1.jpg GRAPHIC 164172
21 GRAPHIC g18728ex99_2p22g1.jpg GRAPHIC 255334
22 GRAPHIC g18728ex99_2p23g1.jpg GRAPHIC 159616
23 GRAPHIC g18728ex99_2p24g1.jpg GRAPHIC 191199
24 GRAPHIC g18728ex99_2p25g1.jpg GRAPHIC 315960
25 GRAPHIC g18728ex99_2p26g1.jpg GRAPHIC 198251
26 GRAPHIC g18728ex99_2p27g1.jpg GRAPHIC 161649
27 GRAPHIC g18728ex99_2p28g1.jpg GRAPHIC 261683
28 GRAPHIC g18728ex99_2p29g1.jpg GRAPHIC 157477
29 GRAPHIC g18728ex99_2p2g1.jpg GRAPHIC 568005
30 GRAPHIC g18728ex99_2p30g1.jpg GRAPHIC 202329
31 GRAPHIC g18728ex99_2p31g1.jpg GRAPHIC 218946
32 GRAPHIC g18728ex99_2p32g1.jpg GRAPHIC 164933
33 GRAPHIC g18728ex99_2p33g1.jpg GRAPHIC 143459
34 GRAPHIC g18728ex99_2p34g1.jpg GRAPHIC 209406
35 GRAPHIC g18728ex99_2p35g1.jpg GRAPHIC 222160
36 GRAPHIC g18728ex99_2p36g1.jpg GRAPHIC 338759
37 GRAPHIC g18728ex99_2p3g1.jpg GRAPHIC 166522
38 GRAPHIC g18728ex99_2p4g1.jpg GRAPHIC 172797
39 GRAPHIC g18728ex99_2p5g1.jpg GRAPHIC 252610
40 GRAPHIC g18728ex99_2p6g1.jpg GRAPHIC 232413
41 GRAPHIC g18728ex99_2p7g1.jpg GRAPHIC 211786
42 GRAPHIC g18728ex99_2p8g1.jpg GRAPHIC 172160
43 GRAPHIC g18728ex99_2p9g1.jpg GRAPHIC 193681
  Complete submission text file 0001193125-25-141756.txt   11335028

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syre-20250617.xsd EX-101.SCH 2832
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE syre-20250617_lab.xml EX-101.LAB 18757
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syre-20250617_pre.xml EX-101.PRE 11698
53 EXTRACTED XBRL INSTANCE DOCUMENT d18728d8k_htm.xml XML 3776
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 251051832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)